Chimerism evaluation after allogeneic haematopoietic stem cell transplantation in children with non malignant diseases.

被引:0
|
作者
Faraci, M. [1 ]
Bagnasco, F. [2 ]
Giardino, S. [1 ]
Terranova, R. [3 ]
Di Luca, M. [4 ]
Di Martino, D. [1 ]
Lanino, E. [1 ]
机构
[1] Inst G Gaslini, Hematopoet Stem Cell Transplant Unit, Genoa, Italy
[2] Inst G Gaslini, Epidemiol & Stat, Genoa, Italy
[3] Inst G Gaslini, Clin & Expt Haematol Unit, Genoa, Italy
[4] Inst G Gaslini, Lab Pathophysiol Uremia, Genoa, Italy
关键词
D O I
暂无
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
P449
引用
收藏
页码:S353 / S353
页数:1
相关论文
共 50 条
  • [41] Transfusion requirements after allogeneic haematopoietic stem cell transplantation
    Bini-Antunes, M
    Santos, L
    Campilho, F
    Rosales, M
    Amado, F
    Campos, A
    Vaz, CP
    Pimentel, P
    Carvalhais, A
    BONE MARROW TRANSPLANTATION, 2004, 33 : S121 - S122
  • [42] Safety of pembrolizumab after allogeneic haematopoietic stem cell transplantation
    Yok-Lam Kwong
    Annals of Hematology, 2016, 95 : 1191 - 1192
  • [43] Cerebral infections after allogeneic haematopoietic stem cell transplantation
    Ditschkowski, M
    Elmaagacli, AH
    Trenschel, R
    Keller, MT
    Schulte, C
    Hlinka, M
    Koldehoff, M
    Beelen, DW
    BONE MARROW TRANSPLANTATION, 2006, 37 : S168 - S168
  • [44] Haemorrhagic cystitis after allogeneic haematopoietic stem cell transplantation
    Al Sabty, F.
    Demeckova, E.
    Bojtarova, E.
    Czako, B.
    Hrubisko, M.
    Kubalova, S.
    Mistrik, M.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S84 - S84
  • [45] Mixed Donor Chimerism in Non-Malignant Haematological Diseases after Allogeneic Bone Marrow Transplantation
    Shamshad, Ghassan Umair
    Ahmed, Suhaib
    Bhatti, Farhat Abbas
    Ali, Nadir
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2012, 22 (12): : 765 - 768
  • [46] Erythropoietin in anaemias after allogeneic haematopoietic stem cell transplantation
    Stadler, M
    Reuter, C
    Varvenne, M
    Elser, C
    Kamal, H
    Eder, M
    Ganser, A
    Hertenstein, B
    BONE MARROW TRANSPLANTATION, 2005, 35 : S186 - S186
  • [47] Safety of pembrolizumab after allogeneic haematopoietic stem cell transplantation
    Kwong, Yok-Lam
    ANNALS OF HEMATOLOGY, 2016, 95 (07) : 1191 - 1192
  • [48] Allogeneic haematopoietic cell transplantation after reduced- intensity conditioning regimen in 19 children with malignant and non- malignant disorders
    Strullu, M.
    Thomas, C.
    Corradini, N.
    Brissot, E.
    Rialland, F.
    Mechinaud, F.
    Mohty, M.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S299 - S299
  • [49] Red blood cell and reticulocyte chimerism studies in non-myeloablative allogeneic peripheral blood haematopoietic stem cell transplantation
    Harritshoj, L
    Berkowicz, A
    Petersen, SL
    Madsen, HO
    Ryder, LP
    Vindelov, L
    Andersen, P
    Dickmeiss, E
    BONE MARROW TRANSPLANTATION, 2004, 33 : S116 - S117
  • [50] The time to complete donor haematopoietic chimerism may predict the outcome of allogeneic stem cell transplantation
    Vadikolia, C.
    Sakellari, I.
    Mallouri, D.
    Batsis, I.
    Bitzioni, A.
    Tahinopoulou, B.
    Stalika, E.
    Zorbas, I.
    Anagnostopoulos, A.
    Fassas, A.
    Papanicolaou, G.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S198 - S199